Novartis Pharmaceuticals Corporation defence contracts and awards
Novartis Pharmaceuticals Corporation is a defence direct supplier based in United States with 1 contract award in our public data worth USD 480k in total, in 2026. Below are its latest awards, main buyers and programmes, each linked to the public source.
Figures counted from our database.
Latest Novartis Pharmaceuticals Corporation contract awards
The five most recent awards in our data, newest first.
| Contract | Buyer | Contractor | Value | Awarded | Ends | Source |
|---|---|---|---|---|---|---|
|
SUPPLY of LUTATHERA® (lutetium Lu 177 dotatate) and PLUVICTO™ (lutetium Lu 177 vipivotide tetraxetan) SAM.gov 8 Oct 2026 (opens the source) |
Defense Health Agency (dha) US | Novartis Pharmaceuticals Corporation | USD 480k | 30 Sep 2026 | n/a | SAM.gov 8 Oct 2026 (opens the source) |
Top buyers
- Defense Health Agency (dha) 1 · USD 480k
Programmes
No programme is linked to this company in our data yet. See all defence programmes.
Supply chain, contacts and full history
Available in every plan for this and every other contractor.
Unlock the full profile
Full award history, suppliers and subcontractors, business contacts and alerts for new awards.
About the Novartis Pharmaceuticals Corporation profile
Where does the data on Novartis Pharmaceuticals Corporation come from?
How much has Novartis Pharmaceuticals Corporation won in defence contracts?
Can I see every award and the full supply chain?
Is something wrong in this profile?
Compare with other defence contractors
See which defence contracts fit your company
Describe what you supply. We score open tenders, prior notices and recompetes against it and show the first matches straight away.
- A fit score with reasons on every row
- Source and publication date on every record
- US, UK, NATO and EU buyers in one search